Rimantadine
Back to searchMolecule Structure
Scientific Name
Rimantadine
Description of the Drug
Rimantadine is an RNA synthesis inhibitor used to prevent influenza A infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00478
http://www.drugbank.ca/drugs/DB00478
Brand Name(s)
Not Available
Company Owner(s)
Sun Pharmaceutical Industries Inc, Forest Laboratories Inc, Impax Laboratories Inc, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Influenza virus A matrix protein M2 | SINGLE PROTEIN | INHIBITOR | CHEMBL2052 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2981 | ||
| PharmGKB | PA164748038 | ||
| Human Metabolome Database | HMDB0014621 | ||
| DrugBank | DB00478 | ||
| PubChem: Thomson Pharma | 15219656 | ||
| PubChem | 5071 | ||
| Mcule | MCULE-9027470290 | ||
| LINCS | LSM-5143 | ||
| BindingDB | 50216627 | ||
| EPA CompTox Dashboard | DTXSID2023561 | ||
| DrugCentral | 2383 | ||
| rxnorm | RIMANTADINE HYDROCHLORIDE | RIMANTADINE | FLUMADINE |
| KEGG Ligand | C07236 | ||
| ChEBI | 94440 |
